Foundation Medicine and Syndax Pharma Unveil Companion Diagnostic in Hematology
Foundation Medicine and Syndax Pharmaceuticals have initiated a partnership to develop a tool to identify acute myeloid leukemia (AML)...
Foundation Medicine and Syndax Pharmaceuticals have initiated a partnership to develop a tool to identify acute myeloid leukemia (AML)...
Atamyo Therapeutics and the Dion Foundation for Rare Diseases have partnered to conduct a clinical trial in the United...
Medidata, a renowned provider of clinical trial solutions, has partnered with Aixial Group, a contract research organization (CRO), to...
Care Access, a global health research company, has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to...
Rafael Holdings and Cyclo Therapeutics announce their merger to advance the development of Trappsol® Cyclo™ for treating Niemann-Pick Disease...
Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) have joined forces to enhance decentralized clinical trials through...
A pivotal Phase 3 trial (inMIND) has demonstrated the efficacy of tafasitamab in combination with lenalidomide and rituximab for...
Medable introduces Medable Studio, a revolutionary application that simplifies and accelerates the process of configuring, translating, and launching eClinical...
Anti-TIGIT antibodies are revolutionizing cancer treatment by targeting the immune inhibitory receptor TIGIT, expressed on T cells and NK...
The global market for eClinical solutions, which streamline clinical trials, is projected to expand rapidly, reaching $21.9 billion by...